Clinical trial
Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer
NCT00170573 · North Eastern German Society of Gynaecological Oncology, Other · Completed
Key facts
| NCT number | NCT00170573 |
|---|---|
| Title | Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer |
| Official title | Comparison of Quality of Life in Patients With Platinum-sensitive Recurrent Ovarian, Fallopian Tube and Peritoneal Cancer When Treated With Treatment With Trabectedin/PLD or Standard Platinum-based Therapy |
| Lead sponsor | North Eastern German Society of Gynaecological Oncology, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | Caelyx |
| Enrollment | 77 |
| Start date | Sep 1, 2001 |
| Primary completion | Apr 1, 2009 |
| Completion | Aug 1, 2010 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 16, 2024 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: